The Medicines and Healthcare products Regulatory Agency has not approved it for any clinical use, and it cannot lawfully be marketed for human consumption, sold as a supplement, or prescribed on the NHS
mTORC1 maintains granuloma structure, while JAK/STAT enhances cytokine production and immune cell activation, they suppress macrophage autophagy and promote formation of multinucleated giant cells, a hallmark of sarcoid granulomas (48)
The GLP-1 Patch Market in 2026: What You're Actually Shopping Into You deserve honest context about the market you're navigating, because it directly affects how you should evaluate any individual product - including GLPatch
One Phase 2 trial of lixisenatide in Parkinsons did meet its primary motor endpoint, the biology of GLP-1 in the brain is real, and questions remain about earlier intervention, specific subpopulations, and whether vascular or metabolic contributions to neurodegeneration might still respond
Who should get a shot and who should avoid it